The effect of an SGLT2 inhibitor on sleep apnea in obese patients with sleep apnea syndrome and type 2 diabetes mellitus.
Latest Information Update: 27 Apr 2018
At a glance
- Drugs Canagliflozin (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 23 Apr 2018 Status changed from recruiting to completed.
- 27 May 2016 New trial record